Cite
MLA Citation
R Panaccione et al.. “A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH CROHN'S DISEASE: 52 WEEK RESULTS FROM THE PHASE 3 FORTIFY STUDY.” Journal of the Canadian Association of Gastroenterology, vol. 5, n.d., pp. 43–45. http://access.bl.uk/ark:/81055/vdc_100151255555.0x00000a